Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204974
- By:
- Publication type:
- Article
Works by Astruc, Béatrice
Results: 5
1
2
Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.
- Published in:
- Human Vaccines & Immunotherapeutics, 2018, v. 14, n. 3, p. 596, doi. 10.1080/21645515.2017.1384106
- By:
- Publication type:
- Article
3
Absolute oral bioavailability of selexipag, a novel oral prostacyclin IP receptor agonist.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 2, p. 151, doi. 10.1007/s00228-016-2164-4
- By:
- Publication type:
- Article
4
Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 4, p. 405, doi. 10.1111/j.1365-2125.2005.02338.x
- By:
- Publication type:
- Article
5
A New Reversible and Potent P2Y Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 807, doi. 10.1007/s40261-014-0236-8
- By:
- Publication type:
- Article